510(k) device
BACT/ALERT MP Reagent System
bioMerieux, Inc. · System, Blood Culturing (MDB, Class I) · First FDA decision Jul 14, 2003, newest May 15, 2019Sepsis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "BACT ALERT MP"
MAUDE reports
84
Brand "BACT ALERT MP", since 2015
PubMed studies
9
Mentioning "BACT ALERT MP"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing BACT/ALERT MP Reagent System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K190405 · Decided May 15, 2019 · 85 days after receipt
Device type: System, Blood Culturing (MDB) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "BACT ALERT MP", any status and sponsor, newest update first.
No registered device study names "BACT ALERT MP".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "BACT ALERT MP", and for the whole product code for context.
This brand
84 reports: 84 malfunction, 0 injury, 0 death
Whole product code MDB
6,473 reports: 6,328 malfunction, 134 injury, 10 death
Newest reports for this brand
- BACT/ALERT MP - 419744Malfunction
3002769706-2019-00124 · Received Dec 6, 2019
Device type: System, Blood Culturing (MDB)
Device problem as coded: Incorrect, Inadequate or Imprecise Result or Readings
Patient problem as coded: No Known Impact Or Consequence To Patient
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "BACT ALERT MP"[tiab]. The summary above synthesizes these.
- Multicenter matched-pair study comparing BACT/ALERT® MP reagent systems for the recovery of mycobacteria from specimens other than blood.
Dwivedi H, MacDonald K, Angaali N, et al. · Diagn Microbiol Infect Dis · 2023Multicenter Study
- A novel liquid media mycobacteria extraction method for MALDI-TOF MS identification using VITEK® MS.
Moreno E, Miller E, Miller E, et al. · J Microbiol Methods · 2018Research Support, Non-U.S. Gov't
- Performance of Vitek MS v3.0 for Identification of Mycobacterium Species from Patient Samples by Use of Automated Liquid Medium Systems.
Miller E, Cantrell C, Beard M, et al. · J Clin Microbiol · 2018Comparative Study, Evaluation Study
- Early diagnosis of extrapulmonary tuberculosis by a new procedure combining broth culture and PCR.
Noussair L, Bert F, Leflon-Guibout V, et al. · J Clin Microbiol · 2009Evaluation Study
- Rapid and specific detection of Mycobacterium tuberculosis from acid-fast bacillus smear-positive respiratory specimens and BacT/ALERT MP culture bottles by using fluorogenic probes and real-time PCR.
Miller N, Cleary T, Kraus G, et al. · J Clin Microbiol · 2002Evaluation Study, Research Support, Non-U.S. Gov't
- Role of GenoType(®) Mycobacterium Common Mycobacteria/Additional Species Assay for Rapid Differentiation Between Mycobacterium tuberculosis Complex and Different Species of Non-Tuberculous Mycobacteria.
Singh AK, Maurya AK, Umrao J, et al. · J Lab Physicians · 2013
- [Evaluation of TB-beads assay utilizing the technique of magnetic beads--an innovative assay method for detection of acid fast bacilli].
Ohkuma M, Ikeda K, Obayashi K, et al. · Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi · 2012Comparative Study, English Abstract
- Post-procedural Wound Infections by Mycobacterium fortuitum: A Series of Seven Cases From Eastern India.
Majumder D, Jana S, Das D, et al. · Cureus · 2026
- Evaluation of a novel kit for use with the BacT/ALERT 3D system for drug susceptibility testing of Mycobacterium tuberculosis.
Werngren J, Klintz L, Hoffner SE · J Clin Microbiol · 2006Evaluation Study
Other devices of this type
Also filed under product code MDB.
- BD BACTEC Plus Aerobic/F Culture VialsBecton, Dickinson and Company · 510(k) 2023
- BacT/ALERT FA PlusbioMerieux, Inc. · 510(k) 2019
- BD BACTEC Peds Plus/F Culture Vials Soybean-Casein Digest Broth with Resins in a Plastic VialBecton, Dickinson and Company · 510(k) 2018
- BD BACTEC Standard/10 Aerobic/F Culture Vials Soybean-Casein Digest Broth in a Plastic VialBecton Dickinson · 510(k) 2017
- Bact/Alert Fn Plus Culture BottlebioMerieux, Inc. · 510(k) 2013
- Bact/Alert Pf Plus Culture BottlebioMerieux, Inc. · 510(k) 2013
- BD BACTEC FXI Culture SystemBD Diagnostic Systems · 510(k) 2026
- BD BACTEC Myco/F Lytic Culture VialsBecton, Dickinson and Company · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.